Symbiox Investme

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE653R01012
  • NSEID:
  • BSEID: 539278
INR
1.61
-0.01 (-0.62%)
BSENSE

Nov 20

BSE+NSE Vol: 14.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Siddha Ventures
Dharani Finance
Symbiox Investme
Sungold Capital
Munoth Commun.
Futuristic Sec.
Vintage Secur.
Delta Industrial
Rajkot Inv.Trust
Lead Financial S
SMC Credits
Why is Symbiox Investment & Trading Co Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.90%
  • Poor long term growth as Operating profit has grown by an annual rate of -1.44%
2
Flat results in Sep 26
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 13-Nov-26
  • The stocks MACD and KST technical factors are also Bearish
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -45.42% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Symbiox Investme for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Symbiox Investme
-45.42%
-0.62
73.09%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-6.00%
EBIT Growth (5y)
-1.44%
Net Debt to Equity (avg)
0
Institutional Holding
0
ROE (avg)
0.90%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
20
Price to Book Value
0.16
EV to EBIT
-12.62
EV to EBITDA
-12.62
EV to Capital Employed
-0.88
EV to Sales
-7.89
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
0.47%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(9M)

Higher at Rs 0.14 Cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Symbiox Investme
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.14 Cr
than preceding 12 month period ended Sep 2026 of Rs -0.16 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)